The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gaich, Gregory, Chien, Jenny Y., Fu, Haoda, Glass, Leonard C., Deeg, Mark A., Holland, William L., Kharitonenkov, Alexei, Bumol, Thomas, Schilske, Holger K., Moller, David E.
Published in Cell metabolism (03.09.2013)
Published in Cell metabolism (03.09.2013)
Get full text
Journal Article
Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Goldberg, Ronald B, Kendall, David M, Deeg, Mark A, Buse, John B, Zagar, Anthony J, Pinaire, Jane A, Tan, Meng H, Khan, Mehmood A, Perez, Alfonso T, Jacober, Scott J
Published in Diabetes care (01.07.2005)
Published in Diabetes care (01.07.2005)
Get full text
Journal Article
Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Deeg, Mark A, Buse, John B, Goldberg, Ronald B, Kendall, David M, Zagar, Anthony J, Jacober, Scott J, Khan, Mehmood A, Perez, Alfonzo T, Tan, Meng H
Published in Diabetes care (01.10.2007)
Published in Diabetes care (01.10.2007)
Get full text
Journal Article
Dual-Monoclonal, Sandwich Immunoassay Specific for Glucose-Dependent Insulinotropic Peptide1-42, the Active Form of the Incretin Hormone
TROUTT, Jason S, SIEGEL, Robert W, JINBIAO CHEN, SLOAN, John H, DEEG, Mark A, GUOQING CAO, KONRAD, Robert J
Published in Clinical chemistry (Baltimore, Md.) (01.06.2011)
Published in Clinical chemistry (Baltimore, Md.) (01.06.2011)
Get full text
Journal Article
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.07.2016)
Published in Diabetes care (01.07.2016)
Get full text
Journal Article
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
Hamdouchi, Chafiq, Kahl, Steven D, Patel Lewis, Anjana, Cardona, Guemalli R, Zink, Richard W, Chen, Keyue, Eessalu, Thomas E, Ficorilli, James V, Marcelo, Marialuisa C, Otto, Keith A, Wilbur, Kelly L, Lineswala, Jayana P, Piper, Jared L, Coffey, D. Scott, Sweetana, Stephanie A, Haas, Joseph V, Brooks, Dawn A, Pratt, Edward J, Belin, Ruth M, Deeg, Mark A, Ma, Xiaosu, Cannady, Ellen A, Johnson, Jason T, Yumibe, Nathan P, Chen, Qi, Maiti, Pranab, Montrose-Rafizadeh, Chahrzad, Chen, Yanyun, Reifel Miller, Anne
Published in Journal of medicinal chemistry (22.12.2016)
Published in Journal of medicinal chemistry (22.12.2016)
Get full text
Journal Article
Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control
Alatorre, Carlos I, Hoogwerf, Byron J, Deeg, Mark A, Nelson, David R, Hunter, Theresa M, Ng, Wee Teck, Rekhter, Mark D
Published in Current medical research and opinion (01.02.2018)
Published in Current medical research and opinion (01.02.2018)
Get more information
Journal Article
Prognostic and predictive biomarkers of abdominal aortic aneurysm growth rate
Deeg, Mark A, Meijer, C Arnoud, Chan, Lai Shan, Shen, Lei, Lindeman, Jan H N
Published in Current medical research and opinion (03.03.2016)
Published in Current medical research and opinion (03.03.2016)
Get more information
Journal Article
Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients
Nicholls, Stephen J, Ruotolo, Giacomo, Brewer, H. Bryan, Wang, Ming-Dauh, Liu, Liping, Willey, Mark B, Deeg, Mark A, Krueger, Kathryn A, Nissen, Steven E
Published in Journal of clinical lipidology (01.05.2016)
Published in Journal of clinical lipidology (01.05.2016)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects
Payne, Christopher D., Deeg, Mark A., Chan, Melanie, Tan, Lai Hock, LaBell, Elizabeth Smith, Shen, Tong, DeBrota, David J.
Published in British journal of clinical pharmacology (01.12.2014)
Published in British journal of clinical pharmacology (01.12.2014)
Get full text
Journal Article
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.06.2017)
Published in Diabetes care (01.06.2017)
Get full text
Journal Article
Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.11.2016)
Published in Diabetes care (01.11.2016)
Get full text
Journal Article
Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes
Deeg, Mark A, Bowen, Rosario F, Williams, Monet D, Olson, L. Karl, Kirk, Elizabeth A, LeBoeuf, Renee C
Published in American journal of physiology: endocrinology and metabolism (01.07.2001)
Published in American journal of physiology: endocrinology and metabolism (01.07.2001)
Get full text
Journal Article